Citing Expert Market Research consultant services data, the company said, ”The market for Ayurvedic products is expected to grow at a CAGR of 15 percent between 2021 and 2026”.”Moving forward on this mission to make Ayurveda more mainstream and accessible to every household, Dabur has now rolled out a new retail initiative christened ‘Ghar Ghar Ayurveda’,” the report said.
Category:
Pandemic
Latest
Expected to vaccinate 60 per cent population within two-three months: Kerala to SC
In an affidavit filed in the apex court in response to an application raising issue of relaxations granted by Kerala because of the Bakrid festival, the state said it has vaccinated 45 percent of its 18+ population with at least one dose and 18 percent have been vaccinated with two doses.
It said the state has taken a “scientific and pragmatic approach” for conceiving and implementing various measures for curbing the spread of pandemic and the strategy is based on a rational balance of life and livelihood.
India’s excess deaths during pandemic up to 4.9 million, study shows
India has officially reported more than 414,000 deaths due to COVID-19, the third highest tally in the world after the United States and Brazil, but the study adds to growing calls from experts for a rigorous nationwide fatality audit.
“What is tragically clear is that too many people, in the millions rather than hundreds of thousands, may have died,” the report said, estimating the excess death toll during the pandemic at between 3.4 million and 4.9 million.
The report did not ascribe all the excess deaths to the pandemic.
Global coronavirus deaths exceed 700,000, one person dies every 15 seconds on average
Even in parts of the world that had appeared to have curbed the spread of the virus, countries have recently seen single-day records in new cases, signaling the battle is far from over. Australia, Japan, Hong Kong, Bolivia, Sudan, Ethiopia, Bulgaria, Belgium, Uzbekistan and Israel all recently had record increases in cases.
Proportion of youth with COVID-19 triples in five months: WHO
An analysis by the WHO of 6 million infections between Feb. 24 and July 12 found that the share of people aged 15-24 years rose to 15% from 4.5%.
Apart from the United States which leads a global tally with 4.8 million total cases, European countries including Spain, Germany and France, and Asian countries such as Japan, have said that many of the newly infected are young people.
“Younger people tend to be less vigilant about masking and social distancing,” Neysa Ernst, nurse manager at Johns Hopkins Hospital’s biocontainment unit in Baltimore, Maryland told Reuters in an email.
How the pandemic may change ‘work-life balance’ forever
Some of the best companies for work-life balance] have really great paid-time off policies, flexible working schedules, good parental leave, sabbaticals and gym credits,” said Amanda Stansell, senior research analyst at workplace website Glassdoor. But as workers shifted to remote work, the spirit of in-person events and company culture needed to be recreated at home
Zydus Cadila’s COVID-19 vaccine candidate found safe in early-stage human trial
Zydus plans to complete late-stage trials for ZyCoV-D by February or March and could produce up to 100 million doses a year initially, the company’s chairman told Reuters last month.
India reported a daily jump of more than 50,000 coronavirus infections for the seventh straight day on Wednesday.Total cases now stand at 1.91 million, the third biggest, after the United States and Brazil
90% of recovered COVID-19 patients in Wuhan suffering from lung damage:report
According to the first phase results, 90 per cent of the patients” lungs are still in a damaged state, which means their lungs ventilation and gas exchange functions have not recovered to the level of healthy people, state-run Global Times reported.
Some recovered patients have to rely on oxygen machines even three months after being discharged from the hospital, Liang Tengxiao, a doctor from the Dongzhimen Hospital, Beijing University of Chinese Medicine, was quoted as saying by the report.
Let Ayushman Bharat guide states to fix the cost of Covid -19 treatment,Centre to SC
CJI Bobde asked the government to urge insurance companies to release dues promptly.
“When there is a pandemic, insurance companies cannot keep their hands off,” he said.
Indian pharma majors race ahead to launch affordable drugs for Covid-19 treatment
Drug major Cipla is working with government agencies to develop a treatment for COVID-19 while ramping up the production of various life saving essential drugs, according to company’s chairman YK Hamied.
Drug firm BDR Pharmaceuticals on Wednesday said it has launched its antiviral drug Favipiravir for the treatment of COVID-19 patients in India at a price of Rs 63 per tablet.
Lupin on Wednesday announced the launch of its Favipiravir drug under the brand name ‘Covihalt’ for the treatment patients with mild to moderate COVID-19 symptoms at Rs 49 per tablet in India.
Disburse pension to elderly on time; provide PPE, face masks to people in old age homes:SC
A bench headed by Justice Ashok Bhushan said this while hearing a plea filed by former Union minister and senior advocate Ashwani Kumar who said that at the time of the pandemic, it is necessary that pension to elderly reaches them on time.
Kumar told the top court that crores of elderly people are living alone and appropriate direction should be issued that pension reaches to those, who are already identified and eligible for it, on time.
Are pharma companies are trying to profiteer from Covid-19 vaccines
If a vaccine proves too expensive or difficult to obtain, those who seek exorbitant profits off of it will be scrutinized far more closely than bankers were after the 2008 crash. Actions like those that have already allowed insiders to pocket $80 million will provoke public revulsion, even if those trades were pre-scheduled. Calls to regulate sectors that take for granted intellectual property protections will grow exponentially. Those demands won’t be fanatical or radical, but mainstream.
India ‘flying blind’, needs better data collection to control Covid-19
India’s death registration data was patchy even before the virus struck. The vast majority of deaths, especially in rural villages, take place at home and routinely go unregistered. For others the cause of death listed is often anodyne — old age or heart attack. Experts believe that only between 20 per cent-30 per cent of all deaths in India are properly medically certified.